<info type="SequenceVariant">Mutation screening</info> of the <info type="GeneOrGeneProduct">GUCA1B</info> gene in patients with <info type="DiseaseOrPhenotypicFeature">autosomal dominant cone and cone rod dystrophy</info>.

Background: <info type="SequenceVariant">Heterozygous mutations</info> in <info type="GeneOrGeneProduct">GUCA1A</info> (<info type="SequenceVariant">MIM # 600364</info>) have been identified to cause <info type="DiseaseOrPhenotypicFeature">autosomal dominantly inherited cone dystrophy</info>, <info type="DiseaseOrPhenotypicFeature">cone rod dystrophy</info> and <info type="DiseaseOrPhenotypicFeature">macular dystrophy</info>. However, the role of <info type="GeneOrGeneProduct">GUCA1B</info> gene mutations in <info type="DiseaseOrPhenotypicFeature">inherited retinal disease</info> has been controversial. We therefore performed a <info type="GeneOrGeneProduct">mutation analysis</info> of the <info type="GeneOrGeneProduct">GUCA1B</info> gene in a clinically well characterized group of patients of <info type="OrganismTaxon">European</info> and <info type="OrganismTaxon">North-American</info> geographical origin with <info type="DiseaseOrPhenotypicFeature">autosomal dominantly inherited cone dystrophy</info> and <info type="DiseaseOrPhenotypicFeature">cone rod dystrophy</info>. Material and Methods: Twenty-four unrelated patients diagnosed with <info type="DiseaseOrPhenotypicFeature">cone dystrophy</info> or <info type="DiseaseOrPhenotypicFeature">cone rod dystrophy</info> according to standard diagnostic criteria and a family history consistent with an <info type="DiseaseOrPhenotypicFeature">autosomal dominant</info> mode of inheritance were included in the study. <info type="GeneOrGeneProduct">Mutation analysis</info> of all coding exons of the <info type="GeneOrGeneProduct">GUCA1B</info> gene was performed by <info type="GeneOrGeneProduct">polymerase chain reaction amplification</info> of <info type="GeneOrGeneProduct">genomic DNA</info> and subsequent <info type="GeneOrGeneProduct">DNA sequencing</info>. Results: Three different <info type="SequenceVariant">sequence variants</info>, <info type="SequenceVariant">c.-17T&gt;C</info>, <info type="SequenceVariant">c.171T&gt;C</info>, <info type="SequenceVariant">c.465G&gt;T</info> were identified. The <info type="SequenceVariant">sequence variant</info> <info type="SequenceVariant">c.465G&gt;T</info> encodes a conservative <info type="SequenceVariant">amino acid substitution</info>, <info type="GeneOrGeneProduct">p.Glu155Asp</info>, located in <info type="GeneOrGeneProduct">EF-hand 4</info>, the <info type="ChemicalEntity">calcium binding site</info> of <info type="GeneOrGeneProduct">GCAP2</info> protein. All <info type="SequenceVariant">sequence variants</info> were previously reported in <info type="DiseaseOrPhenotypicFeature">healthy subjects</info>. Conclusion: The absence of clearly pathogenic mutations in the selected patient group suggests that the <info type="GeneOrGeneProduct">GUCA1B</info> gene is a minor cause for <info type="DiseaseOrPhenotypicFeature">retinal degenerations</info> in <info type="OrganismTaxon">Europeans</info> or <info type="OrganismTaxon">North-Americans</info>.